.svg)
Clinically Advanced
WHY {PRODUCT NAME}
Effectiveness Against Biofilm
In vitro laboratory data shows that revyve™ Antimicrobial Wound Gel disrupts the polymeric matrix enhancing the inactivation of biofilm embedded microorganisms, and aids in inhibiting metalloprotease activity.
Critical Proteases That Can Impair Healing
Chronic wounds have a prolonged inflammatory phase which hinders the normal wound healing process. These wounds are often colonized by biofilm forming bacteria that can trigger the inflammatory process and elevate levels of matrix metalloproteases. These enzymes often cause tissue damage.
Spray Version Coming Soon!
All of the same amazing benefits of revyve Antimicrobial Wound Gel but in an easy to apply spray that gels on contact.
Technology
Biofilm impaired healing - the largest unresolved problem in wound care.
Studies have reported a prevalence of biofilms in over 78% of chronic wounds. Biofilms are a glue-like substance excreted by bacteria and/or fungi to attach to surfaces. They protect and allow bacteria to survive and thrive in hostile environments. Biofilms make bacteria up to 1,000 times more resistant to antibiotics and antimicrobials and are one of the main contributors to antibiotic resistance. This is where revyve steps in.
Want To Try revyve?
Kane Biotech has signed an exclusive distribution agreement with ProgenaCare Global LLC for revyve™ Antimicrobial Wound Gel in the United States wound care market.
To order revyve™ click the button below and a member of our team will be in touch.
{Area Name} is Venture OneView™ Compatible!
